To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene GPR75andASB3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
376 supporting clones for gene GPR75andASB3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC314536 amygdala GPR75andASB3.a 1 to 468 1 to 474   tiling clone,   474/474
(100 %)
8 diff
(98.4 %id)
NM_001164165.1   GPR75andASB3.a 129 to 2088 1 to 1960 exact RefSeq, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1960/1960
(100 %)
0 diff
(100 %id)
BP350378 brain GPR75andASB3.a 129 to 710 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA080065 cerebellum GPR75andASB3.a 174 to 748 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DB168761 kidney, tumor tissue GPR75andASB3.a 174 to 743 2 to 573   capped   570/572
(99 %)
2 diff
(99.7 %id)
DA201990 brain GPR75andASB3.a 176 to 751 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA349354 substantia nigra GPR75andASB3.a 194 to 749 2 to 557   capped   556/557
(99 %)
1 diff
(99.9 %id)
BG702192 brain, hippocampus GPR75andASB3.a 195 to 1016 1 to 824       824/824
(100 %)
13 diff
(98.5 %id)
BC110915 Brain, adult, 6 pooled whole brains GPR75andASB3.a 207 to 2088 1 to 1882 exact tiling clone, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1882/1882
(100 %)
0 diff
(100 %id)
BM926369 brain GPR75andASB3.a 218 to 834 1 to 618       618/1279
(48 %)
14 diff
(99.0 %id)
BG994372 head_neck GPR75andASB3.a 333 to 819 506 to 21       486/516
(94 %)
3 diff
(99.5 %id)
CN363162 embryonic stem cells, cell lines H1, H7, andH9 GPR75andASB3.a 333 to 1022 27 to 717       694/717
(96 %)
7 diff
(99.1 %id)
BF966396.
matches multiple genes
brain, hippocampus GPR75andASB3.a 333 to 981 25 to 679     also hits gene CCND3 658/698
(94 %)
14 diff
(98.0 %id)
BQ072442 pooled lung and spleen GPR75andASB3.a 333 to 1255 29 to 961       936/1054
(88 %)
47 diff
(95.6 %id)
BE266590 lung, small cell carcinoma GPR75andASB3.a 337 to 961 1 to 642       642/656
(97 %)
30 diff
(95.5 %id)
BG113223 Bone, osteosarcoma, cell line GPR75andASB3.a 346 to 1085 1 to 748       748/759
(98 %)
30 diff
(96.1 %id)
CV026602 mixed GPR75andASB3.a 348 to 996 1 to 648       648/651
(99 %)
3 diff
(99.6 %id)
TI_1948146536   GPR75andASB3.a 348 to 953 126 to 732       607/1338
(45 %)
8 diff
(99.5 %id)
TI_1948146537   GPR75andASB3.a 348 to 1332 126 to 1120       995/1277
(77 %)
44 diff
(96.6 %id)
TI_1948146848   GPR75andASB3.a 348 to 1046 124 to 828       705/1276
(55 %)
23 diff
(98.2 %id)
TI_1948146849   GPR75andASB3.a 348 to 1129 127 to 908       782/1326
(58 %)
19 diff
(98.6 %id)
TI_1948145897   GPR75andASB3.a 354 to 1323 133 to 1100       968/1268
(76 %)
26 diff
(98.0 %id)
TI_1948146206   GPR75andASB3.a 354 to 1100 129 to 877       749/1223
(61 %)
24 diff
(98.1 %id)
TI_1948146207   GPR75andASB3.a 354 to 1325 129 to 1104       976/1271
(76 %)
25 diff
(98.1 %id)
BG994381 head_neck GPR75andASB3.a 367 to 819 481 to 27       455/481
(94 %)
1 diff
(99.8 %id)
CN363163 embryonic stem cells, cell lines H1, H7, andH9 GPR75andASB3.a 376 to 844 1 to 469       469/469
(100 %)
0 diff
(100 %id)
BU507769 leiomyosarcoma, uterus GPR75andASB3.a 429 to 1289 1 to 870       870/895
(97 %)
14 diff
(98.5 %id)
BQ312091 breast_normal GPR75andASB3.a 459 to 1054 16 to 610       595/615
(96 %)
12 diff
(98.1 %id)
BG538887 lung GPR75andASB3.a 484 to 1054 1 to 571       571/571
(100 %)
4 diff
(99.3 %id)
CA396323 eye, RPE/choroid GPR75andASB3.a 540 to 1126 1 to 587       587/587
(100 %)
0 diff
(100 %id)
DB490297 hypothalamus GPR75andASB3.a 541 to 953 27 to 438       415/439
(94 %)
9 diff
(98.0 %id)
TI_44185931   GPR75andASB3.a 541 to 1241 53 to 754       702/754
(93 %)
7 diff
(99.1 %id)
R97538 liver and spleen GPR75andASB3.a 570 to 890 1 to 323     Submitted on the opposite strand 323/323
(100 %)
2 diff
(99.4 %id)
T55524 fetal spleen, Spleen GPR75andASB3.a 645 to 931 1 to 289       289/290
(99 %)
5 diff
(98.3 %id)
DT220767 brain GPR75andASB3.a 707 to 1222 1 to 516       516/516
(100 %)
0 diff
(100 %id)
BE930569 placenta_normal GPR75andASB3.a 794 to 1160 11 to 377       367/377
(97 %)
7 diff
(98.2 %id)
DR760629 embryonic stem GPR75andASB3.a 805 to 1616 1 to 812       812/812
(100 %)
1 diff
(99.9 %id)
TI_1948146850   GPR75andASB3.a 947 to 1903 1087 to 128       960/1290
(74 %)
20 diff
(98.5 %id)
TI_1948146208   GPR75andASB3.a 951 to 1903 1079 to 128       952/1299
(73 %)
19 diff
(98.6 %id)
TI_1948146538   GPR75andASB3.a 951 to 1903 1080 to 129       952/1261
(75 %)
19 diff
(98.5 %id)
TI_1948146209   GPR75andASB3.a 954 to 1903 1095 to 131       965/1490
(64 %)
37 diff
(97.6 %id)
TI_1948146539   GPR75andASB3.a 955 to 1903 1079 to 132       948/1438
(65 %)
51 diff
(96.5 %id)
BX391049   GPR75andASB3.a 1011 to 1940 1 to 924       924/927
(99 %)
16 diff
(98.3 %id)
AL528198 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized GPR75andASB3.a 1014 to 2060 1045 to 1       1045/1049
(99 %)
12 diff
(98.9 %id)
FN169566 breast carcinoma GPR75andASB3.a 1051 to 1129 91 to 11     Submitted on the opposite strand 81/92
(88 %)
0 diff
(100 %id)
BM466955 duodenal adenocarcinoma, cell line, small intestine GPR75andASB3.a 1055 to 1992 1 to 942       942/1115
(84 %)
23 diff
(98.0 %id)
BX401652   GPR75andASB3.a 1077 to 2084 1 to 1008   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 1008/1011
(99 %)
10 diff
(99.1 %id)
AA365754 pineal body GPR75andASB3.a 1262 to 1586 1 to 327       327/328
(99 %)
4 diff
(98.8 %id)
BF769494 epid_tumor GPR75andASB3.a 1328 to 1576 138 to 386       249/386
(64 %)
2 diff
(99.5 %id)
R27237 placenta GPR75andASB3.a 1356 to 1716 1 to 365       365/431
(84 %)
7 diff
(98.4 %id)
H40739 brain GPR75andASB3.a 1390 to 1716 1 to 328       328/380
(86 %)
2 diff
(99.5 %id)
FN068727 breast carcinoma GPR75andASB3.a 1399 to 1492 1 to 101       101/110
(91 %)
6 diff
(94.6 %id)
EC567595 Prostate GPR75andASB3.a 1428 to 1534 106 to 1       106/106
(100 %)
1 diff
(99.1 %id)
EC494907 Prostate GPR75andASB3.a 1429 to 1534 103 to 1       103/103
(100 %)
3 diff
(97.1 %id)
EC552388 Prostate GPR75andASB3.a 1429 to 1534 103 to 1       103/103
(100 %)
3 diff
(97.1 %id)
EH343988   GPR75andASB3.a 1494 to 1553 1 to 60       60/60
(100 %)
1 diff
(98.4 %id)
FN114004 breast carcinoma GPR75andASB3.a 1548 to 1641 1 to 95       95/98
(96 %)
5 diff
(94.9 %id)
H41008 brain GPR75andASB3.a 1717 to 2070 358 to 1       358/365
(98 %)
8 diff
(97.9 %id)
R27441 placenta GPR75andASB3.a 1793 to 2082 295 to 3       293/295
(99 %)
0 diff
(100 %id)
N98717 multiple sclerosis lesions GPR75andASB3.b-u 1 to 365 1 to 369   tiling clone,   369/377
(97 %)
5 diff
(98.7 %id)
AI220134 anaplastic oligodendroglioma, brain GPR75andASB3.b-u 167 to 719 544 to 1   tiling clone,   544/615
(88 %)
22 diff
(96.5 %id)
BX100475 whole brain GPR75andASB3.b-u 237 to 731 496 to 3   tiling clone, Submitted on the opposite strand 494/496
(99 %)
0 diff
(100 %id)
R15743 whole brain GPR75andASB3.b-u 255 to 728 483 to 1       483/488
(98 %)
12 diff
(97.6 %id)
BE671266 carcinoid, lung GPR75andASB3.b-u 377 to 700 1 to 324     Submitted on the opposite strand 324/324
(100 %)
0 diff
(100 %id)
N66110 multiple sclerosis lesions GPR75andASB3.b-u 382 to 720 338 to 1   tiling clone,   338/338
(100 %)
1 diff
(99.8 %id)
CN412668 embryonic stem cells, cell lines H1, H7, andH9 GPR75andASB3.b-u 430 to 1143 1 to 712   tiling clone,   712/712
(100 %)
4 diff
(99.5 %id)
BE937141 stomach_normal GPR75andASB3.b-u 967 to 1603 637 to 1       637/637
(100 %)
13 diff
(98.0 %id)
BQ366875 placenta_normal GPR75andASB3.b-u 990 to 1243 1 to 256       256/256
(100 %)
5 diff
(98.1 %id)
BC067475 PCR rescued clones GPR75andASB3.b-u 995 to 2908 1 to 1913 L175P N278D available from MGC,   1913/1913
(100 %)
5 diff
(99.8 %id)
CD559588 mixed GPR75andASB3.b-u 996 to 1728 36 to 760       725/806
(89 %)
17 diff
(97.9 %id)
DN693360 mixed GPR75andASB3.b-u 1070 to 1563 1 to 492       492/693
(70 %)
16 diff
(97.7 %id)
CD559658 mixed GPR75andASB3.b-u 1073 to 1812 33 to 772       740/772
(95 %)
6 diff
(99.3 %id)
BC067476 PCR rescued clones GPR75andASB3.b-u 1075 to 2816 1 to 1741 exact tiling clone, available from MGC,   1741/1741
(100 %)
1 diff
(100.0 %id)
CU451722 epidermis GPR75andASB3.b-u 1075 to 1306 247 to 16     Submitted on the opposite strand 232/260
(89 %)
0 diff
(100 %id)
CU454553 epidermis GPR75andASB3.b-u 1075 to 1306 247 to 16     Submitted on the opposite strand 232/286
(81 %)
0 diff
(100 %id)
CU444569 epidermis GPR75andASB3.b-u 1081 to 1315 241 to 7     Submitted on the opposite strand 235/283
(83 %)
0 diff
(100 %id)
TI_1948233411   GPR75andASB3.b-u 1102 to 1924 125 to 954   fully sequenced,   830/954
(87 %)
21 diff
(97.8 %id)
TI_1948233567   GPR75andASB3.b-u 1102 to 1961 129 to 984   fully sequenced,   856/984
(86 %)
11 diff
(98.9 %id)
EL736782 mixed GPR75andASB3.b-u 1107 to 1722 1 to 616       616/616
(100 %)
1 diff
(99.9 %id)
EC566502 Prostate GPR75andASB3.b-u 1658 to 1758 1 to 100       100/100
(100 %)
1 diff
(99.0 %id)
TI_1948233412   GPR75andASB3.b-u 1894 to 2733 967 to 122   fully sequenced,   846/967
(87 %)
24 diff
(97.6 %id)
TI_1948233568   GPR75andASB3.b-u 1931 to 2733 935 to 121   fully sequenced,   815/935
(87 %)
14 diff
(98.6 %id)
CD559503 mixed GPR75andASB3.b-u 2047 to 2823 782 to 9     Submitted on the opposite strand 774/782
(98 %)
0 diff
(100 %id)
CD559746 mixed GPR75andASB3.b-u 2195 to 2905 724 to 18     Submitted on the opposite strand 707/806
(87 %)
0 diff
(100 %id)
AA019197 eye, retina GPR75andASB3.b-u 2524 to 2950 428 to 1   tiling clone,   428/431
(99 %)
1 diff
(99.8 %id)
BE764641 nervous_tumor GPR75andASB3.b-u 2525 to 3142 12 to 625   tiling clone,   614/637
(96 %)
20 diff
(96.9 %id)
AK314885 brain GPR75andASB3.c 1 to 1893 2 to 1894 exact tiling clone,   1894/1894
(100 %)
0 diff
(100 %id)
NM_006794.2   GPR75andASB3.c 1 to 2114 2 to 2115 exact RefSeq,   2115/2115
(100 %)
0 diff
(100 %id)
DA248816 brain GPR75andASB3.c 1 to 582 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
BP201531 amygdala GPR75andASB3.c 22 to 599 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
DB177856 kidney, tumor tissue GPR75andASB3.c 23 to 452 2 to 431   capped   430/430
(100 %)
0 diff
(100 %id)
BP360578 thalamus GPR75andASB3.c 36 to 617 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DR003478 fetal brain GPR75andASB3.c 37 to 772 8 to 743       736/743
(99 %)
8 diff
(99.0 %id)
AF072693 retinal GPR75andASB3.c 58 to 2114 1 to 2054 exact tiling clone,   2054/2054
(100 %)
3 diff
(99.9 %id)
H85783 eye, retina GPR75andASB3.c 58 to 437 1 to 387       387/410
(94 %)
13 diff
(96.9 %id)
AA021025 eye, retina GPR75andASB3.c 58 to 496 1 to 443       443/443
(100 %)
10 diff
(97.8 %id)
AA020972 eye, retina GPR75andASB3.c 1759 to 2114 356 to 1       356/356
(100 %)
5 diff
(98.6 %id)
H84878 eye, retina GPR75andASB3.c 1811 to 2103 293 to 1       293/293
(100 %)
1 diff
(99.7 %id)
BX401526   GPR75andASB3.d 1 to 541 1 to 544   tiling clone,   544/544
(100 %)
16 diff
(97.1 %id)
CB997544 placenta, pre-eclamptic placenta GPR75andASB3.d 27 to 541 28 to 542       515/845
(60 %)
8 diff
(99.1 %id)
TI_57163111   GPR75andASB3.d 30 to 777 32 to 779       748/779
(96 %)
6 diff
(99.3 %id)
BI838472 pooled pancreas and spleen GPR75andASB3.d 35 to 777 1 to 743       743/743
(100 %)
0 diff
(100 %id)
BE566066 bladder, carcinoma, cell line GPR75andASB3.d 42 to 539 1 to 506       506/604
(83 %)
15 diff
(97.6 %id)
NM_016115.3   GPR75andASB3.d 52 to 2265 1 to 2214 exact RefSeq,   2214/2214
(100 %)
0 diff
(100 %id)
AK000985 whole embryo, mainly head GPR75andASB3.d 59 to 1927 1 to 1869 exact tiling clone, available from FLJ,   1869/1869
(100 %)
1 diff
(100.0 %id)
AU118131 whole embryo, mainly head GPR75andASB3.d 60 to 881 2 to 826   capped   825/831
(99 %)
9 diff
(99.0 %id)
DB034936 testis GPR75andASB3.d 64 to 541 8 to 485   capped   478/484
(98 %)
2 diff
(99.6 %id)
BG163544 hypernephroma, cell line, Kidney GPR75andASB3.d 65 to 732 1 to 675       675/1170
(57 %)
19 diff
(98.4 %id)
BX341802   GPR75andASB3.d 69 to 1141 1 to 1064       1064/1064
(100 %)
14 diff
(98.7 %id)
TI_57216231   GPR75andASB3.d 69 to 900 32 to 865       832/866
(96 %)
13 diff
(98.5 %id)
BG397674 B-cells, primary B-cells from tonsils (cell line) GPR75andASB3.d 72 to 899 1 to 827       827/827
(100 %)
6 diff
(99.3 %id)
BG341102 B-cells, primary B-cells from tonsils (cell line) GPR75andASB3.d 72 to 697 1 to 628       628/632
(99 %)
13 diff
(98.0 %id)
BG685434 B-cells, primary B-cells from tonsils (cell line) GPR75andASB3.d 72 to 958 1 to 890       890/890
(100 %)
46 diff
(94.9 %id)
BI758094 brain GPR75andASB3.d 73 to 900 1 to 830       828/831
(99 %)
7 diff
(99.2 %id)
DA824633 pericardium GPR75andASB3.d 73 to 633 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
CA394206 eye, RPE/choroid GPR75andASB3.d 78 to 645 1 to 568       568/568
(100 %)
0 diff
(100 %id)
DB043461 testis GPR75andASB3.d 79 to 645 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
AA306763   GPR75andASB3.d 86 to 597 1 to 512       512/512
(100 %)
1 diff
(99.9 %id)
BF026813 melanotic melanoma, skin GPR75andASB3.d 89 to 943 1 to 850       850/869
(97 %)
33 diff
(96.3 %id)
DA591310 lung GPR75andASB3.d 90 to 658 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
DA006392   GPR75andASB3.d 91 to 645 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB192794 ovary, tumor tissue GPR75andASB3.d 94 to 641 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DW459588 Liver GPR75andASB3.d 110 to 242 14 to 146       133/146
(91 %)
6 diff
(95.9 %id)
CD706955 normal nasopharynx GPR75andASB3.d 117 to 431 38 to 356       319/356
(89 %)
10 diff
(97.2 %id)
DA610964   GPR75andASB3.d 117 to 680 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
DA617739   GPR75andASB3.d 117 to 651 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DB193879 ovary, tumor tissue GPR75andASB3.d 117 to 688 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
CD300516 testis GPR75andASB3.d 119 to 968 29 to 884       856/893
(95 %)
21 diff
(97.7 %id)
AU116978 whole embryo, mainly head GPR75andASB3.d 120 to 671 2 to 553   capped   552/648
(85 %)
10 diff
(98.5 %id)
AL711136 human skeletal muscle GPR75andASB3.d 121 to 553 1 to 433       433/433
(100 %)
2 diff
(99.6 %id)
DB481855 hippocampus GPR75andASB3.d 122 to 541 1 to 420       420/431
(97 %)
0 diff
(100 %id)
DB497498 hypothalamus GPR75andASB3.d 122 to 620 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
CB107621 Liver GPR75andASB3.d 123 to 353 1 to 231       231/231
(100 %)
1 diff
(99.6 %id)
DB121262 thymus GPR75andASB3.d 123 to 681 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DB265557 uterus GPR75andASB3.d 123 to 698 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BC009569 Kidney, hypernephroma GPR75andASB3.d 127 to 2094 1 to 1967 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1967/1967
(100 %)
2 diff
(99.9 %id)
BU507034 leiomyosarcoma, uterus GPR75andASB3.d 128 to 1009 11 to 896       886/917
(96 %)
24 diff
(97.4 %id)
AA471282   GPR75andASB3.d 129 to 538 1 to 409       409/491
(83 %)
15 diff
(97.0 %id)
BM470581 eye, retinoblastoma GPR75andASB3.d 129 to 909 1 to 788       788/964
(81 %)
25 diff
(97.5 %id)
DA693582   GPR75andASB3.d 132 to 703 2 to 573   capped   572/573
(99 %)
2 diff
(99.7 %id)
DA538849 Kidney GPR75andASB3.d 134 to 715 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
AU129144   GPR75andASB3.d 134 to 785 2 to 653   capped   652/655
(99 %)
3 diff
(99.6 %id)
DB112750 thymus GPR75andASB3.d 134 to 709 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
CN363161 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 GPR75andASB3.d 139 to 791 6 to 658       653/672
(97 %)
7 diff
(99.0 %id)
BI913657 brain GPR75andASB3.d 142 to 910 1 to 772       772/781
(98 %)
3 diff
(99.7 %id)
CX870041 embryonic stem GPR75andASB3.d 142 to 873 1 to 732       732/732
(100 %)
0 diff
(100 %id)
TI_57241420   GPR75andASB3.d 142 to 910 35 to 806       772/815
(94 %)
8 diff
(99.1 %id)
BP871958 embryonal kidney GPR75andASB3.d 144 to 721 1 to 577       577/582
(99 %)
6 diff
(99.0 %id)
DA496698 brain GPR75andASB3.d 145 to 736 2 to 593   capped   592/592
(100 %)
2 diff
(99.7 %id)
DA841216 placenta GPR75andASB3.d 145 to 692 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BM832701 stomach GPR75andASB3.d 145 to 838 1 to 694       694/694
(100 %)
0 diff
(100 %id)
DB028548 testis GPR75andASB3.d 145 to 741 2 to 598   capped   597/597
(100 %)
2 diff
(99.7 %id)
BP201080 amygdala GPR75andASB3.d 146 to 541 1 to 397       397/583
(68 %)
8 diff
(98.7 %id)
DA180529 amygdala GPR75andASB3.d 146 to 703 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA979411 synovial membrane tissue from rheumatioidarthritis GPR75andASB3.d 146 to 658 2 to 516   capped   515/523
(98 %)
4 diff
(99.3 %id)
DB119543 thymus GPR75andASB3.d 146 to 685 6 to 545   capped   540/544
(99 %)
1 diff
(99.9 %id)
DB463655 hippocampus GPR75andASB3.d 153 to 531 1 to 381       381/427
(89 %)
23 diff
(94.7 %id)
BM013266 brain, neuroblastoma, cell line GPR75andASB3.d 154 to 968 1 to 810       810/875
(92 %)
25 diff
(97.2 %id)
TI_59380143   GPR75andASB3.d 155 to 968 127 to 935       809/874
(92 %)
24 diff
(97.3 %id)
BC006488 Lung, small cell carcinoma GPR75andASB3.d 174 to 1927 1 to 1755 exact available from MGC, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1755/1755
(100 %)
1 diff
(100.0 %id)
AK222595 coronary artery GPR75andASB3.d 175 to 1927 1 to 1753 E157D AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1753/1753
(100 %)
7 diff
(99.7 %id)
AA284002 germinal center B cell GPR75andASB3.d 178 to 451 1 to 274       274/274
(100 %)
10 diff
(96.4 %id)
AF156778   GPR75andASB3.d 187 to 1743 1 to 1557 exact     1557/1557
(100 %)
1 diff
(100.0 %id)
CR590535 Neuroblastoma Cot 50-normalized GPR75andASB3.d 187 to 1899 1 to 1713 exact     1713/1713
(100 %)
0 diff
(100 %id)
AL530554 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized GPR75andASB3.d 187 to 1046 1 to 859   fully sequenced,   859/859
(100 %)
14 diff
(98.4 %id)
AK222715 colon GPR75andASB3.d 203 to 2082 1 to 1881   tiling clone, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1881/1881
(100 %)
6 diff
(99.7 %id)
AL563775 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized GPR75andASB3.d 1016 to 1899 883 to 1   fully sequenced,   883/883
(100 %)
30 diff
(96.7 %id)
BX401525   GPR75andASB3.d 1167 to 1897 731 to 1       731/734
(99 %)
11 diff
(98.6 %id)
AU143925 whole embryo, mainly head GPR75andASB3.d 1375 to 1927 553 to 1       553/555
(99 %)
7 diff
(98.8 %id)
AU144778 whole embryo, mainly head GPR75andASB3.d 1415 to 1927 511 to 1       511/551
(92 %)
11 diff
(98.1 %id)
AU151323   GPR75andASB3.d 1418 to 1927 510 to 1       510/550
(92 %)
13 diff
(97.7 %id)
AA285075 germinal center B cell GPR75andASB3.d 1490 to 1935 446 to 1       446/446
(100 %)
0 diff
(100 %id)
AK056069   GPR75andASB3.e 1 to 2110 2 to 2111 exact tiling clone, available from FLJ,   2111/2111
(100 %)
5 diff
(99.8 %id)
DA533184 brain GPR75andASB3.e 1 to 563 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA687556   GPR75andASB3.e 1 to 524 2 to 525   capped   524/528
(99 %)
4 diff
(99.3 %id)
DA523285 brain GPR75andASB3.e 2 to 450 2 to 450   capped   449/449
(100 %)
2 diff
(99.6 %id)
DA524205 brain GPR75andASB3.e 2 to 560 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DA775160 brain GPR75andASB3.e 2 to 565 2 to 566   tiling clone, capped   565/565
(100 %)
3 diff
(99.5 %id)
AL703755 human skeletal muscle GPR75andASB3.e 27 to 324 1 to 297       297/300
(99 %)
4 diff
(98.7 %id)
DB323005   GPR75andASB3.e 1567 to 2110 544 to 1       544/544
(100 %)
1 diff
(99.9 %id)
AW628538 pooled GPR75andASB3.e 1718 to 2113 396 to 1       396/396
(100 %)
2 diff
(99.5 %id)
BG203149   GPR75andASB3.e 1733 to 2106 34 to 404   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 371/404
(91 %)
6 diff
(98.6 %id)
H42997 brain GPR75andASB3.e 1739 to 2099 370 to 3       368/413
(89 %)
0 diff
(100 %id)
AA633496 breast GPR75andASB3.e 1741 to 2110 370 to 1       370/370
(100 %)
1 diff
(99.8 %id)
BG190877   GPR75andASB3.e 1743 to 2110 8 to 372   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 365/372
(98 %)
6 diff
(98.4 %id)
DB534164 hippocampus GPR75andASB3.e 1746 to 2110 1 to 369   AAA Submitted on the opposite strand 369/369
(100 %)
6 diff
(98.4 %id)
AA857563 adenocarcinoma, colon GPR75andASB3.e 1785 to 2112 328 to 1       328/328
(100 %)
1 diff
(99.7 %id)
DB550695 hippocampus GPR75andASB3.e 1787 to 2279 1 to 493     Submitted on the opposite strand 493/494
(99 %)
2 diff
(99.6 %id)
DB568019 hypothalamus GPR75andASB3.e 1795 to 2270 1 to 476     Submitted on the opposite strand 476/476
(100 %)
0 diff
(100 %id)
DB506825 testis GPR75andASB3.e 1797 to 2271 1 to 478     Submitted on the opposite strand 478/478
(100 %)
13 diff
(97.3 %id)
AW628525 pooled GPR75andASB3.e 1804 to 2116 313 to 1       313/313
(100 %)
0 diff
(100 %id)
AI628662 Kidney GPR75andASB3.e 1807 to 2279 480 to 7       474/480
(98 %)
0 diff
(100 %id)
AI197805 anaplastic oligodendroglioma, brain GPR75andASB3.e 1810 to 2114 305 to 1       305/305
(100 %)
0 diff
(100 %id)
BM805690 brain, hippocampus GPR75andASB3.e 1811 to 2350 136 to 676       541/1227
(44 %)
18 diff
(98.6 %id)
CA430526 Cell Line, Chondrosarcoma GPR75andASB3.e 1813 to 2448 647 to 19   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 629/629
(100 %)
7 diff
(98.9 %id)
AW591033 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus GPR75andASB3.e 1821 to 2110 290 to 1       290/290
(100 %)
0 diff
(100 %id)
AA291017.
matches multiple genes
germinal center B cell GPR75andASB3.e 1829 to 2108 286 to 6     also hits gene IWS1 281/288
(97 %)
0 diff
(100 %id)
T55443 fetal spleen, Spleen GPR75andASB3.e 1830 to 2113 290 to 1       290/392
(73 %)
11 diff
(97.2 %id)
AI824520 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors GPR75andASB3.e 1830 to 2118 289 to 1       289/289
(100 %)
0 diff
(100 %id)
DB555315 hypothalamus GPR75andASB3.e 1849 to 2268 1 to 420     Submitted on the opposite strand 420/422
(99 %)
3 diff
(99.3 %id)
DB560404 hypothalamus GPR75andASB3.e 1860 to 2271 1 to 414   AAA Submitted on the opposite strand 414/414
(100 %)
6 diff
(98.6 %id)
AI814031 normal prostate, Prostate GPR75andASB3.e 1860 to 2271 412 to 1       412/412
(100 %)
0 diff
(100 %id)
DN918319   GPR75andASB3.e 1868 to 2447 575 to 1       575/575
(100 %)
4 diff
(99.4 %id)
DB563976 hypothalamus GPR75andASB3.e 1870 to 2271 1 to 406   AAA Submitted on the opposite strand 406/406
(100 %)
5 diff
(98.8 %id)
AI468806 lymph node, lymphoma, follicular mixed small and largecell GPR75andASB3.e 1881 to 2111 231 to 1       231/231
(100 %)
3 diff
(98.8 %id)
AW294842   GPR75andASB3.e 1883 to 2127 245 to 1       245/255
(96 %)
0 diff
(100 %id)
R23837 placenta GPR75andASB3.e 1888 to 2311 1 to 426       426/429
(99 %)
18 diff
(95.9 %id)
BF222852 pooled germ cell tumors GPR75andASB3.e 1901 to 2119 219 to 1       219/219
(100 %)
0 diff
(100 %id)
BE671919 pooled germ cell tumors GPR75andASB3.e 1902 to 2119 218 to 1       218/218
(100 %)
0 diff
(100 %id)
BI493093 cochlea, ear GPR75andASB3.e 1914 to 2130 1 to 217       217/217
(100 %)
11 diff
(95.0 %id)
FN054452 breast carcinoma GPR75andASB3.e 1916 to 2026 1 to 112       112/112
(100 %)
2 diff
(98.3 %id)
AI659449 Prostate GPR75andASB3.e 1916 to 2119 204 to 1       204/204
(100 %)
0 diff
(100 %id)
DW421940 Liver GPR75andASB3.e 1929 to 2213 17 to 296       280/296
(94 %)
6 diff
(98.0 %id)
BM723171 eye, fetal eye GPR75andASB3.e 1955 to 2110 1 to 156   fully sequenced, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 156/156
(100 %)
0 diff
(100 %id)
DB567481 hypothalamus GPR75andASB3.e 1975 to 2447 1 to 472     Submitted on the opposite strand 472/473
(99 %)
2 diff
(99.6 %id)
AU144567.
matches multiple genes
whole embryo, mainly head GPR75andASB3.e 1977 to 2448 473 to 1     also hits gene merare 473/646
(73 %)
3 diff
(99.6 %id)
DB547734 hippocampus GPR75andASB3.e 1978 to 2406 1 to 431     Submitted on the opposite strand 431/437
(98 %)
2 diff
(99.6 %id)
DB548082 hippocampus GPR75andASB3.e 1986 to 2448 1 to 464   AAA Submitted on the opposite strand 464/464
(100 %)
5 diff
(99.0 %id)
AI469184 Kidney GPR75andASB3.e 1998 to 2279 289 to 7       283/289
(97 %)
0 diff
(100 %id)
BF431200 Kidney GPR75andASB3.e 1998 to 2448 462 to 12   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 451/451
(100 %)
4 diff
(99.2 %id)
DB558848 hypothalamus GPR75andASB3.e 2001 to 2449 1 to 449   tiling clone, Submitted on the opposite strand 449/458
(98 %)
2 diff
(99.6 %id)
DB552397 hippocampus GPR75andASB3.e 2004 to 2448 1 to 446   AAA Submitted on the opposite strand 446/446
(100 %)
2 diff
(99.6 %id)
DB549456 hippocampus GPR75andASB3.e 2012 to 2448 1 to 438   AAA Submitted on the opposite strand 438/438
(100 %)
1 diff
(99.8 %id)
BU741882 eye, fetal eye GPR75andASB3.e 2018 to 2128 111 to 1   fully sequenced, Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 111/111
(100 %)
0 diff
(100 %id)
BU675796 lung, Primary Lung Epithelial Cells GPR75andASB3.e 2074 to 2271 1 to 204   AAA Submitted on the opposite strand 204/204
(100 %)
7 diff
(96.6 %id)
BF196173 carcinoid, lung GPR75andASB3.e 2113 to 2449 342 to 6       337/342
(98 %)
0 diff
(100 %id)
AW304358 lung, two pooled squamous cell carcinomas GPR75andASB3.e 2172 to 2448 277 to 1       277/277
(100 %)
0 diff
(100 %id)
AW304369 lung, two pooled squamous cell carcinomas GPR75andASB3.e 2172 to 2448 277 to 1       277/277
(100 %)
0 diff
(100 %id)
BY999428   GPR75andASB3.e 2220 to 2449 1 to 230     Submitted on the opposite strand 230/232
(99 %)
1 diff
(99.6 %id)
DA038561   GPR75andASB3.f 1 to 562 2 to 563   tiling clone, capped   562/562
(100 %)
0 diff
(100 %id)
DB479063 hippocampus GPR75andASB3.f 41 to 546 1 to 506       506/506
(100 %)
0 diff
(100 %id)
DN993070 brain, whole brain GPR75andASB3.f 53 to 689 43 to 676       634/676
(93 %)
9 diff
(98.7 %id)
DA141492 alzheimer cortex GPR75andASB3.f 57 to 607 2 to 552   capped   551/553
(99 %)
7 diff
(98.8 %id)
AK001283   GPR75andASB3.f 67 to 1733 1 to 1667 L45S tiling clone, available from FLJ,   1667/1667
(100 %)
3 diff
(99.9 %id)
AU309733 neuroblastoma GPR75andASB3.f 67 to 612 1 to 546       546/550
(99 %)
0 diff
(100 %id)
NM_145863.1   GPR75andASB3.f 67 to 2071 1 to 2005 exact RefSeq,   2005/2005
(100 %)
0 diff
(100 %id)
AU126149   GPR75andASB3.f 68 to 774 2 to 714   capped   713/737
(96 %)
19 diff
(97.5 %id)
BI550858 brain, hippocampus GPR75andASB3.f 69 to 910 1 to 845       845/854
(98 %)
18 diff
(97.9 %id)
TI_44172193   GPR75andASB3.f 74 to 910 89 to 928       840/937
(89 %)
20 diff
(97.9 %id)
R60471 whole brain GPR75andASB3.f 106 to 464 1 to 364       364/389
(93 %)
8 diff
(98.0 %id)
DB492892 hypothalamus GPR75andASB3.f 160 to 616 1 to 456       456/456
(100 %)
3 diff
(99.4 %id)
DB496459 hypothalamus GPR75andASB3.f 160 to 654 1 to 495       495/495
(100 %)
1 diff
(99.8 %id)
BI522872 brain GPR75andASB3.f 163 to 886 1 to 725       725/725
(100 %)
1 diff
(99.9 %id)
BG036388 adenocarcinoma, cell line, Prostate GPR75andASB3.f 171 to 931 1 to 755       755/838
(90 %)
22 diff
(97.4 %id)
R54342 whole brain GPR75andASB3.f 229 to 411 1 to 183     Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 183/184
(99 %)
1 diff
(99.5 %id)
AA164607   GPR75andASB3.f 234 to 635 1 to 403       403/403
(100 %)
12 diff
(97.1 %id)
BM724678 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid GPR75andASB3.f 527 to 1152 1 to 626   fully sequenced,   626/626
(100 %)
0 diff
(100 %id)
TI_1948146851   GPR75andASB3.f 770 to 1548 902 to 128       775/1369
(56 %)
7 diff
(99.5 %id)
TI_1948145898   GPR75andASB3.f 775 to 1548 904 to 129       776/1214
(63 %)
8 diff
(99.4 %id)
CB409239 maxilla, pooled GPR75andASB3.f 809 to 1401 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
BE567689 bladder, carcinoma, cell line GPR75andASB3.f 830 to 1445 1 to 619       619/733
(84 %)
14 diff
(98.1 %id)
TI_149315093   GPR75andASB3.f 886 to 1733 913 to 78   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 836/1002
(83 %)
19 diff
(98.2 %id)
BQ720491 sympathetic trunk GPR75andASB3.f 937 to 1800 1 to 866       866/916
(94 %)
32 diff
(96.6 %id)
BQ719716 sympathetic trunk GPR75andASB3.f 937 to 1612 1 to 677       677/989
(68 %)
15 diff
(98.5 %id)
AJ712252 heart GPR75andASB3.f 972 to 1501 14 to 543       531/543
(97 %)
6 diff
(98.9 %id)
TI_1948145899   GPR75andASB3.f 977 to 1548 709 to 139       571/1403
(40 %)
8 diff
(99.5 %id)
BF818869 colon_ins GPR75andASB3.f 991 to 1549 19 to 577       559/593
(94 %)
8 diff
(98.7 %id)
H18320 brain GPR75andASB3.f 1034 to 1392 1 to 364   fully sequenced,   364/364
(100 %)
3 diff
(99.2 %id)
BQ008535 Chondrosarcoma, Left Pubic Bone GPR75andASB3.f 1051 to 1751 701 to 1   tiling clone,   701/701
(100 %)
0 diff
(100 %id)
BU632861 cell lines, Chondrosarcoma GPR75andASB3.f 1053 to 1751 699 to 1       699/699
(100 %)
4 diff
(99.5 %id)
TI_149280687   GPR75andASB3.f 1060 to 1733 737 to 64   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 674/675
(99 %)
23 diff
(96.6 %id)
BQ045119 lung, Primary Lung Cystic Fibrosis EpithelialCells GPR75andASB3.f 1065 to 1751 684 to 1       684/686
(99 %)
3 diff
(99.6 %id)
CA425425 cell lines, Chondrosarcoma GPR75andASB3.f 1089 to 1751 662 to 1       662/662
(100 %)
3 diff
(99.6 %id)
BU632871 cell lines, Chondrosarcoma GPR75andASB3.f 1098 to 1751 654 to 1       654/654
(100 %)
1 diff
(99.9 %id)
BU538052 adenocarcinoma, cell line, breast GPR75andASB3.f 1103 to 1733 678 to 45   AAA Submitted on the opposite strand 634/906
(69 %)
5 diff
(99.5 %id)
BU741347 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid GPR75andASB3.f 1122 to 1751 630 to 1   fully sequenced,   630/630
(100 %)
0 diff
(100 %id)
BU679388 lung, Primary Lung Epithelial Cells GPR75andASB3.f 1197 to 1751 555 to 1       555/555
(100 %)
4 diff
(99.3 %id)
BQ184561 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid GPR75andASB3.f 1197 to 1751 555 to 1       555/570
(97 %)
2 diff
(99.7 %id)
AA007679 liver and spleen GPR75andASB3.f 1207 to 1734 535 to 1       536/535
(100 %)
13 diff
(97.6 %id)
TI_154135121   GPR75andASB3.f 1224 to 2071 924 to 76   tiling clone, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 849/987
(86 %)
11 diff
(98.9 %id)
BG188219   GPR75andASB3.f 1225 to 1733 1 to 505   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 503/505
(99 %)
7 diff
(98.7 %id)
BG199530   GPR75andASB3.f 1225 to 1425 1 to 201       199/203
(98 %)
10 diff
(95.1 %id)
BG207858   GPR75andASB3.f 1226 to 1729 1 to 505   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 505/508
(99 %)
9 diff
(98.3 %id)
BG192379   GPR75andASB3.f 1232 to 1733 1 to 502   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 502/502
(100 %)
3 diff
(99.5 %id)
BG219379   GPR75andASB3.f 1232 to 1733 10 to 508   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 498/508
(98 %)
6 diff
(98.9 %id)
BG195437   GPR75andASB3.f 1239 to 1732 14 to 506       493/931
(52 %)
12 diff
(98.8 %id)
BE938836 testis_normal GPR75andASB3.f 1246 to 1620 374 to 1       374/374
(100 %)
2 diff
(99.5 %id)
BG207305   GPR75andASB3.f 1248 to 1733 16 to 497   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 482/497
(96 %)
6 diff
(98.8 %id)
AA992134   GPR75andASB3.f 1258 to 1738 481 to 1       481/481
(100 %)
0 diff
(100 %id)
AI824156 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) GPR75andASB3.f 1258 to 1739 482 to 1       482/482
(100 %)
0 diff
(100 %id)
W90763 liver and spleen GPR75andASB3.f 1264 to 1734 477 to 1       477/479
(99 %)
11 diff
(97.8 %id)
AI683111 serous papillary carcinoma, high grade, 2pooled tumors, uterus GPR75andASB3.f 1271 to 1429 159 to 1       159/159
(100 %)
0 diff
(100 %id)
AI678134 Prostate GPR75andASB3.f 1278 to 1736 459 to 1       459/459
(100 %)
4 diff
(99.2 %id)
AI969345 pooled germ cell tumors GPR75andASB3.f 1280 to 1747 468 to 1       468/468
(100 %)
0 diff
(100 %id)
DW423552 Liver GPR75andASB3.f 1284 to 1558 17 to 291       275/291
(94 %)
6 diff
(98.0 %id)
BE205793 muscle, rhabdomyosarcoma GPR75andASB3.f 1295 to 1737 443 to 1       443/443
(100 %)
3 diff
(99.4 %id)
H41506 brain GPR75andASB3.f 1305 to 1733 433 to 1       433/433
(100 %)
5 diff
(98.9 %id)
F32166 pectoral muscle (after mastectomy) GPR75andASB3.f 1308 to 1643 1 to 336       336/336
(100 %)
3 diff
(99.2 %id)
AA693613 liver and spleen GPR75andASB3.f 1313 to 1734 421 to 1       421/421
(100 %)
2 diff
(99.6 %id)
AI659548 Prostate GPR75andASB3.f 1316 to 1739 424 to 1       424/424
(100 %)
9 diff
(97.9 %id)
W86041 liver and spleen GPR75andASB3.f 1319 to 1719 403 to 1       403/403
(100 %)
3 diff
(99.3 %id)
BM931108 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid GPR75andASB3.f 1325 to 1733 1 to 409   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 409/409
(100 %)
0 diff
(100 %id)
AI123276   GPR75andASB3.f 1327 to 1739 413 to 1       413/413
(100 %)
1 diff
(99.8 %id)
AA680001   GPR75andASB3.f 1329 to 1429 101 to 1       101/101
(100 %)
2 diff
(98.1 %id)
AA620806   GPR75andASB3.f 1330 to 1740 411 to 1       411/411
(100 %)
2 diff
(99.6 %id)
H18321 brain GPR75andASB3.f 1331 to 1722 405 to 12   fully sequenced,   394/405
(97 %)
1 diff
(99.8 %id)
AI674320 Prostate GPR75andASB3.f 1331 to 1733 403 to 1       403/403
(100 %)
1 diff
(99.8 %id)
DB534162 hippocampus GPR75andASB3.f 1337 to 1733 1 to 397   AAA Submitted on the opposite strand 397/397
(100 %)
2 diff
(99.5 %id)
R60237 whole brain GPR75andASB3.f 1362 to 1742 384 to 1       384/432
(88 %)
4 diff
(99.1 %id)
AA164608   GPR75andASB3.f 1403 to 1736 335 to 1       335/344
(97 %)
1 diff
(99.8 %id)
R54343 whole brain GPR75andASB3.f 1424 to 1888 481 to 12   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 470/484
(97 %)
6 diff
(98.8 %id)
DB489365 hypothalamus GPR75andASB3.g 1 to 475 1 to 475   tiling clone,   475/475
(100 %)
12 diff
(97.5 %id)
DC295056 synovial membrane tissue from rheumatioidarthritis GPR75andASB3.g 3 to 583 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA831067 placenta GPR75andASB3.g 4 to 662 2 to 668   tiling clone, capped   667/736
(90 %)
11 diff
(98.6 %id)
DB441906 testis GPR75andASB3.g 24 to 455 1 to 432       432/432
(100 %)
1 diff
(99.8 %id)
BF183000 large cell carcinoma, lung GPR75andASB3.g 29 to 676 1 to 641   tiling clone,   641/939
(68 %)
19 diff
(98.0 %id)
DA634061 Kidney GPR75andASB3.g 39 to 614 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DA043650 bladder GPR75andASB3.g 42 to 606 2 to 570   capped   565/569
(99 %)
3 diff
(99.5 %id)
DA933729 Spleen GPR75andASB3.g 53 to 619 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
CD706788 normal nasopharynx GPR75andASB3.g 54 to 645 17 to 608       592/608
(97 %)
9 diff
(98.6 %id)
BX490426   GPR75andASB3.g 61 to 627 1 to 567   tiling clone,   567/567
(100 %)
0 diff
(100 %id)
DA880230 Prostate GPR75andASB3.g 64 to 610 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
BG327815 Kidney, renal cell adenocarcinoma GPR75andASB3.g 68 to 642 1 to 581       581/843
(68 %)
33 diff
(96.1 %id)
DA082608 cerebellum GPR75andASB3.g 70 to 631 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
AL711215 human skeletal muscle GPR75andASB3.g 70 to 639 1 to 570       570/570
(100 %)
1 diff
(99.9 %id)
BP872939 embryonal kidney GPR75andASB3.g 70 to 651 1 to 582   tiling clone,   582/582
(100 %)
2 diff
(99.7 %id)
DA880878   GPR75andASB3.g 71 to 599 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DB058507 testis GPR75andASB3.g 71 to 597 2 to 530   capped   529/529
(100 %)
2 diff
(99.7 %id)
DB108829 thymus GPR75andASB3.g 71 to 651 2 to 583   capped   582/582
(100 %)
4 diff
(99.4 %id)
DA137764 alzheimer cortex GPR75andASB3.g 72 to 646 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DB106684 thymus GPR75andASB3.g 72 to 633 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DB376538 placenta GPR75andASB3.g 1391 to 1870 482 to 1   tiling clone,   482/494
(97 %)
9 diff
(98.2 %id)
BX343364   GPR75andASB3.h 1 to 1096 1 to 1086 P312X L313X T314X C318X D319X ... tiling clone,   1086/1104
(98 %)
14 diff
(98.8 %id)
DA377564 thalamus GPR75andASB3.i 1 to 560 2 to 559   tiling clone, capped   558/558
(100 %)
2 diff
(99.7 %id)
TI_154195230   GPR75andASB3.i 72 to 1019 51 to 991 N204X K226X C242X N243Y I262S ... tiling clone,   938/1039
(90 %)
19 diff
(98.2 %id)
BG471235 eye, retinoblastoma GPR75andASB3.j 1 to 805 1 to 812 E24D N25K Y26L I27H K28* tiling clone,   812/889
(91 %)
18 diff
(98.0 %id)
DA159924 amygdala GPR75andASB3.k 1 to 553 2 to 555   tiling clone, capped   554/554
(100 %)
2 diff
(99.7 %id)
BI464017 testis GPR75andASB3.k 530 to 1189 1 to 660       660/660
(100 %)
6 diff
(99.1 %id)
BF666308 brain, primitive neuroectoderm GPR75andASB3.k 540 to 1180 1 to 637       637/896
(71 %)
19 diff
(97.9 %id)
BF666312 brain, primitive neuroectoderm GPR75andASB3.k 540 to 1176 1 to 634   tiling clone,   634/901
(70 %)
9 diff
(99.1 %id)
BF668233 brain, primitive neuroectoderm GPR75andASB3.k 540 to 1177 1 to 634       634/861
(73 %)
15 diff
(98.3 %id)
BM923577 pooled colon, kidney, stomach GPR75andASB3.k 550 to 1490 1 to 943 A203S N204K V205C N206Q C207L ... tiling clone,   943/1041
(90 %)
22 diff
(97.9 %id)
CB960400 Human Placenta, placenta GPR75andASB3.k 559 to 1264 28 to 737       710/742
(95 %)
9 diff
(98.8 %id)
DA055686 cerebellum GPR75andASB3.k 567 to 1124 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BG714031 brain, hypothalamus GPR75andASB3.k 635 to 1380 1 to 752   tiling clone,   752/752
(100 %)
11 diff
(98.6 %id)
DB057403 testis GPR75andASB3.k 635 to 1162 2 to 530   capped   529/529
(100 %)
1 diff
(99.9 %id)
DB486332 hypothalamus GPR75andASB3.k 640 to 1059 1 to 420       420/420
(100 %)
1 diff
(99.8 %id)
DB488433 hypothalamus GPR75andASB3.k 640 to 1095 1 to 456       456/456
(100 %)
0 diff
(100 %id)
DA611492   GPR75andASB3.k 650 to 1110 2 to 463   capped   462/462
(100 %)
3 diff
(99.4 %id)
AA355988   GPR75andASB3.k 660 to 974 1 to 316       316/316
(100 %)
2 diff
(99.4 %id)
AW965777   GPR75andASB3.k 661 to 1345 1 to 686   tiling clone,   686/686
(100 %)
12 diff
(98.3 %id)
BP873357 embryonal kidney GPR75andASB3.k 662 to 1244 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
DA603775   GPR75andASB3.k 663 to 1159 2 to 499   capped   498/498
(100 %)
1 diff
(99.8 %id)
CB955747 Pooled-Glandular GPR75andASB3.l 1 to 560 5 to 567   tiling clone,   567/787
(72 %)
9 diff
(98.9 %id)
TI_159712527   GPR75andASB3.l 135 to 996 949 to 96   tiling clone, AAA   854/1004
(85 %)
10 diff
(99.1 %id)
CB851924 Human Lung Epithelial cells, lung GPR75andASB3.l 250 to 996 763 to 17   AAA   747/747
(100 %)
0 diff
(100 %id)
BE061630 breast GPR75andASB3.l 392 to 909 1 to 518       518/518
(100 %)
3 diff
(99.5 %id)
DC405511 thymus GPR75andASB3.m 1 to 559 1 to 559   tiling clone,   559/559
(100 %)
0 diff
(100 %id)
BP235816 coronary artery GPR75andASB3.m 87 to 667 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP355569   GPR75andASB3.m 175 to 761 1 to 587   tiling clone,   587/587
(100 %)
6 diff
(99.0 %id)
BP355602   GPR75andASB3.m 181 to 764 1 to 583       583/583
(100 %)
7 diff
(98.8 %id)
BI600003 brain, hypothalamus GPR75andASB3.n 1 to 774 1 to 772 E20K G21A N22M V23L V25S ... tiling clone,   772/772
(100 %)
15 diff
(98.1 %id)
TI_45215650   GPR75andASB3.n 6 to 774 99 to 865 E20K G21A N22M V23L V25S ...     767/865
(88 %)
16 diff
(98.2 %id)
DA682411 ovary GPR75andASB3.o 1 to 558 2 to 559   tiling clone, capped   558/558
(100 %)
1 diff
(99.9 %id)
BE276514 melanotic melanoma, skin GPR75andASB3.o 218 to 835 1 to 614   tiling clone,   614/616
(99 %)
10 diff
(98.4 %id)
BE391309 endometrium, adenocarcinoma cell line, uterus GPR75andASB3.o 218 to 614 1 to 397       397/397
(100 %)
0 diff
(100 %id)
TI_45209299   GPR75andASB3.p 1 to 734 92 to 825 F182L G184D H185M E186K D187I ...     742/825
(89 %)
8 diff
(99.1 %id)
BI596441 brain, hypothalamus GPR75andASB3.p 1 to 734 5 to 738 F182L G184D H185M E186K D187I ... tiling clone,   738/738
(100 %)
5 diff
(99.4 %id)
DC353447 brain GPR75andASB3.q 1 to 561 1 to 564   tiling clone,   564/568
(99 %)
6 diff
(99.0 %id)
BP353480   GPR75andASB3.q 1 to 581 1 to 581 N189X tiling clone,   581/581
(100 %)
2 diff
(99.7 %id)
BF667488 brain, primitive neuroectoderm GPR75andASB3.q 38 to 561 1 to 514       514/882
(58 %)
19 diff
(97.9 %id)
BF701402 brain, primitive neuroectoderm GPR75andASB3.q 38 to 561 1 to 526       526/816
(64 %)
14 diff
(98.3 %id)
BF699498 brain, primitive neuroectoderm GPR75andASB3.q 38 to 561 1 to 528       528/877
(60 %)
22 diff
(97.5 %id)
BF698806 brain, primitive neuroectoderm GPR75andASB3.q 39 to 561 1 to 531       531/834
(63 %)
19 diff
(97.8 %id)
DB053152 testis GPR75andASB3.r 1 to 572 2 to 573 exact tiling clone, capped   572/572
(100 %)
0 diff
(100 %id)
BP204612 coronary artery GPR75andASB3.s 1 to 582 1 to 582 exact tiling clone,   582/582
(100 %)
0 diff
(100 %id)
DB119607 thymus GPR75andASB3.t 1 to 526 2 to 528 D27G T28H C29V S30L T31Y ... tiling clone, capped   527/527
(100 %)
3 diff
(99.5 %id)
DA262923 caudate nucleus GPR75andASB3.u 1 to 555 2 to 556 exact tiling clone, capped   555/555
(100 %)
0 diff
(100 %id)
AK091809 lung GPR75andASB3.va-u 1 to 1919 2 to 1920 exact tiling clone, available from FLJ,   1920/1920
(100 %)
0 diff
(100 %id)
AX747197   GPR75andASB3.va-u 1 to 1919 2 to 1920 exact     1920/1920
(100 %)
0 diff
(100 %id)
DA584702 lung GPR75andASB3.va-u 1 to 584 2 to 588   capped   587/587
(100 %)
3 diff
(99.5 %id)
AI076068 B-cell, chronic lymphotic leukemia GPR75andASB3.va-u 300 to 519 263 to 44   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 220/263
(83 %)
0 diff
(100 %id)
DA101583 cerebellum GPR75andASB3.va-u 900 to 1445 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BG928693 cartilage GPR75andASB3.va-u 1181 to 1719 620 to 82 S108R S109A W110G D111T Y112T ...     539/556
(96 %)
0 diff
(100 %id)
DB319360 lung GPR75andASB3.va-u 1367 to 1919 553 to 1       553/553
(100 %)
0 diff
(100 %id)
DC384796   GPR75andASB3.vb 1 to 560 2 to 562 exact tiling clone,   565/565
(100 %)
3 diff
(99.5 %id)
AL698731 human skeletal muscle GPR75andASB3.vc-u 1 to 547 1 to 548   tiling clone,   548/548
(100 %)
1 diff
(99.9 %id)
BM719736 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid GPR75andASB3.vc-u 768 to 1420 1 to 653   tiling clone, AAA   653/653
(100 %)
0 diff
(100 %id)
AI888389 poorly differentiated adenocarcinoma withsignet ring cell features, stomach GPR75andASB3.vc-u 907 to 1419 517 to 5       513/517
(99 %)
0 diff
(100 %id)
BX109667 poorly differentiated adenocarcinoma withsignet ring cell features, stomach GPR75andASB3.vc-u 1160 to 1419 274 to 15   AAA   260/260
(100 %)
0 diff
(100 %id)
AI984936 Kidney GPR75andASB3.vd 1 to 364 366 to 0 R3P D6N S16F D18N A19R ... tiling clone,   366/366
(100 %)
11 diff
(97.0 %id)
BX643926   GPR75andASB3.ve-u 1 to 693 1 to 691 exact tiling clone,   691/691
(100 %)
4 diff
(99.5 %id)
DB479386 hippocampus GPR75andASB3.ve-u 652 to 1114 1 to 463       463/463
(100 %)
7 diff
(98.5 %id)
DB480687 hippocampus GPR75andASB3.ve-u 652 to 1144 1 to 493   tiling clone,   493/493
(100 %)
4 diff
(99.2 %id)
BP312304 brain GPR75andASB3.vf 1 to 582 1 to 582 V54A tiling clone,   582/582
(100 %)
3 diff
(99.5 %id)
BP373946 umbilical cord GPR75andASB3.vg 1 to 576 1 to 576 N64X N85X I88N I89H tiling clone,   576/581
(99 %)
4 diff
(99.4 %id)
DC366670   GPR75andASB3.vh 1 to 574 2 to 575 C11R tiling clone,   575/575
(100 %)
3 diff
(99.5 %id)
DA340859 substantia nigra GPR75andASB3.vi 1 to 492 2 to 493 exact tiling clone, capped   492/492
(100 %)
1 diff
(99.8 %id)
BP428963   GPR75andASB3.vj-u 1 to 344 7 to 350 exact tiling clone,   344/350
(98 %)
0 diff
(100 %id)
DT217113 brain GPR75andASB3.vk-u 1 to 227 1 to 227 R21T R39T R43I A46S G49* tiling clone,   227/227
(100 %)
9 diff
(96.1 %id)
BG011627 placenta_normal Gene GPR75andASB3, variant not shown              
CN293554 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 Gene GPR75andASB3, variant not shown              
GD157786   Gene GPR75andASB3, variant not shown       AAA      
R52656 whole brain Gene GPR75andASB3, variant not shown              
R53314 whole brain Gene GPR75andASB3, variant not shown              
R59584 whole brain Gene GPR75andASB3, variant not shown              
R59642 whole brain Gene GPR75andASB3, variant not shown              
H10562 whole brain Gene GPR75andASB3, variant not shown              
N64176 multiple sclerosis lesions Gene GPR75andASB3, variant not shown       fully sequenced,      
N64177 multiple sclerosis lesions Gene GPR75andASB3, variant not shown       fully sequenced,      
? Gene Summary Gene on genome mRNA:.a, .b-u, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va-u, .vb, .vc-u, .vd, .ve-u, .vf, .vg, .vh, .vi, .vj-u, .vk-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI